Skip to main content

Table 1 HALE, CEHALE (with 95% confidence intervals) and potential gain in HALE (with increasing proportion*) after eliminating four NCDs in 1990

From: Potential gains in health-adjusted life expectancy from reducing four main non-communicable diseases among Chinese elderly

Age group

HALE without elimination

Elimination of

CVD

CRD

Cancers

DM

CEHALE

∆HALE

CEHALE

∆HALE

CEHALE

∆HALE

CEHALE

∆HALE

Males

60–64

12.35 (11.54, 13.06)

15.78 (14.84, 16.61)

3.43 (27.77)

14.24 (13.34, 15.03)

1.89 (15.30)

13.86 (12.96, 14.65)

1.51 (12.23)

12.52 (11.17, 13.19)

0.17 (1.38)

65–69

9.52 (8.84, 10.12)

12.69 (11.88, 13.41)

3.17 (33.30)

11.34 (10.57, 12.02)

1.82 (19.12)

10.69 (9.94, 11.36)

1.18 (12.39)

9.66 (9.01, 10.23)

0.14 (1.47)

70–74

7.04 (6.49, 7.53)

9.91 (9.24, 10.52)

2.87 (40.77)

8.76 (8.11, 9.34)

1.72 (24.43)

7.90 (7.29, 8.44)

0.86 (12.22)

7.15 (6.63, 7.61)

0.11 (1.56)

75–79

5.37 (4.92, 5.79)

7.88 (7.31, 8.41)

2.51 (46.74)

6.89 (6.34, 7.39)

1.52 (28.31)

5.93 (5.44, 6.38)

0.56 (10.43)

5.46 (5.03, 5.85)

0.08 (1.49)

80–84

3.97 (3.60, 4.30)

6.14 (5.65, 6.58)

2.17 (54.66)

5.28 (4.82, 5.70)

1.32 (33.25)

4.30 (3.91, 4.66)

0.34 (8.56)

4.03 (3.67, 4.35)

0.06 (1.51)

85+

2.57 (2.31, 2.80)

4.58 (4.19, 4.92)

2.01 (78.21)

3.77 (3.41, 4.09)

1.20 (46.69)

2.83 (2.54, 3.08)

0.26 (10.12)

2.61 (2.36, 2.84)

0.04 (1.56)

Females

60–64

14.38 (13.33, 15.32)

18.72 (17.47, 19.83)

4.34 (30.18)

16.35 (15.18, 17.40)

1.98 (13.77)

15.47 (14.34, 16.48)

1.09 (7.58)

14.62 (13.63, 15.51)

0.24 (1.67)

65–69

11.29 (10.40, 12.09)

15.36 (14.26, 16.33)

4.07 (36.05)

13.20 (12.18, 14.11)

1.91 (16.92)

12.15 (11.19, 13.01)

0.86 (7.62)

11.49 (10.64, 12.25)

0.20 (1.77)

70–74

8.55 (7.82, 9.20)

12.29 (11.36, 13.11)

3.74 (43.74)

10.35 (9.49, 11.12)

1.81 (21.17)

9.19 (8.41, 9.88)

0.64 (7.49)

8.70 (8.01, 9.33)

0.16 (1.87)

75–79

6.44 (5.85, 6.98)

9.81 (9.02, 10.51)

3.37 (52.33)

8.06 (7.35, 8.70)

1.62 (25.16)

6.87 (6.24, 7.44)

0.43 (6.68)

6.56 (6.00, 7.07)

0.12 (1.86)

80–84

4.73 (4.25, 5.16)

7.76 (7.08, 8.36)

3.03 (64.06)

6.15 (5.55, 6.69)

1.42 (30.02)

5.00 (4.49, 5.45)

0.27 (5.71)

4.81 (4.35, 5.23)

0.08 (1.69)

85+

3.25 (2.89, 3.57)

6.07 (5.51, 6.57)

2.82 (86.77)

4.56 (4.08, 4.98)

1.31 (40.31)

3.45 (3.07, 3.79)

0.20 (6.15)

3.31 (2.96, 3.62)

0.06 (1.85)

  1. Note: * This increasing proportion means the ratio of ∆HALE to HALE without elimination in the corresponding age interval
  2. HALE health-adjusted life expectancy, CEHALE cause-elimination health-adjusted life expectancy, ∆HALE potential gain in HALE after eliminating a disease, NCDs non-communicable diseases, CVD cardiovascular diseases, CRD chronic respiratory diseases, DM diabetes mellitus
Back to article page

BMC Geriatrics

ISSN: 1471-2318

Contact us